Rob C. Hoeben

A transductionally retargeted adenoviral vector for virotherapy of Her2/neu-expressing prostate cancer.

R. Kraaij, R. Leadley, W. M. Weerden, 2012, Human gene therapy.

Adenovirus 5 vector genetically re-targeted by an Affibody molecule with specificity for tumor antigen HER2/neu

N. Habib, S. Ståhl, S. S. Hong, 2007, Cancer Gene Therapy.

Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer

A. Schambach, M. Cavazzana‐Calvo, F. Staal, 2011, Leukemia.

Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients

M. Havenga, J. Goudsmit, C. Dirven, 2007, Cancer Gene Therapy.

How not to be seen: immune-evasion strategies in gene therapy

R. Hoeben, A. Zaldumbide, Rob C. Hoeben, 2008, Gene Therapy.

Insertion vectors for gene therapy

R. Hoeben, H. J. Rademaker, F. Schagen, 2000, Gene Therapy.